An Indian Perspective on HIV-associated Lymphomas

por Barta, Stefan K.
Publicado 2013

Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas

por Bhansali, Rahul S., Barta, Stefan K.
Publicado 2023

A Rare Association: Autoimmune Hemolytic Anemia With Indolent T-Cell Prolymphocytic Leukemia

por Yahya, Hafiz A, Khan, Nadia, Barta, Stefan, Nejati, Reza
Publicado 2020

Advances and Personalized Approaches in the Frontline Treatment of T-Cell Lymphomas

por Angelos, Mathew G., Ballard, Hatcher J., Barta, Stefan K.
Publicado 2022

New antibody approaches to lymphoma therapy

por Suresh, Tejas, Lee, Lisa X, Joshi, Jitesh, Barta, Stefan K
Publicado 2014

Linked-In: Design and Efficacy of Antibody Drug Conjugates in Oncology

por Feld, Jonathan, Barta, Stefan K., Schinke, Carolina, Braunschweig, Ira, Zhou, Yiyu, Verma, Amit
Publicado 2013

Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma

por Barta, Stefan K, Lee, Jeannette Y, Sparano, Joseph A, Kaplan, Lawrence D, Noy, Ariela
Publicado 2010

Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma

por Shastri, Aditi, Janakiram, Murali, Mantzaris, Ioannis, Yu, Yiting, Londono, Jaime S., Verma, Amit K., Barta, Stefan K.
Publicado 2017

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma

por Ratner, Lee, Ramos, JC, Noy, Ariela, Barta, Stefan, Parikh, Samir, Phillips, Adrienne, Ambinder, Richard, Rauch, Dan, Harding, John, Baydoun, Hicham, Cheng, Xiaogang, Caruso, Breanna, Jacobson, Steven
Publicado 2015

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lympho...

por Johnston, Patrick B., Cashen, Amanda F., Nikolinakos, Petros G., Beaven, Anne W., Barta, Stefan Klaus, Bhat, Gajanan, Hasal, Steven J., De Vos, Sven, Oki, Yasuhiro, Deng, Changchun, Foss, Francine M.
Publicado 2021

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

por Matasar, Matthew J., Luminari, Stefano, Barr, Paul M., Barta, Stefan K., Danilov, Alexey V., Hill, Brian T., Phillips, Tycel J., Jerkeman, Mats, Magagnoli, Massimo, Nastoupil, Loretta J., Persky, Daniel O., Okosun, Jessica
Publicado 2019

T100: Long term Follow-up of a Phase I Study Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A trial of the ECO...

por Diefenbach, Catherine, Jegede, Opeyemi, Ambinder, Richard, Cohen, Jonathon, Robertson, Michael, David, Kevin, Advani, Ranjana, Fenske, Timothy, Barta, Stefan, Palmisiano, Neil, Svoboda, Jakub, Morgan, David, Karmali, Reem, Kahl, Brad, Ansell, Stephen M.
Publicado 2022

Safety and Efficacy of Sars-Cov-2 Vaccines in Hodgkin Lymphoma Patients Receiving PD-1 Inhibitors

por Svoboda, Jakub, Ballard, Hatcher J, Ho, Carrie I, Hughes, Mitchell E., Chong, Elise A, Duca, Adam, Prischak, Sara, Dwivedy Nasta, Sunita, Ruella, Marco, Landsburg, Daniel J, Barta, Stefan K., Gerson, James N, Schuster, Stephen J.
Publicado 2021

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)

por Phillips, Adrienne, Fields, Paul, Hermine, Olivier, Taylor, Graham P, Delioukina, Maria, Horwitz, Steven, Ramos, Juan C, Meniane, Jean-Côme, Barta, Stefan K, Brites, Carlos, Pereria, Juliana, Beltran, Brady, Casanova, Luis, Wandroo, Farooq, Feldman, Tatyana, Dwyer, Karen, Kurman, Michael, Conlon, Kevin
Publicado 2015

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

por Annunzio, Kaitlin, Grover, Natalie S., Welkie, Rina Li, Torka, Pallawi, Watkins, Marcus P., Anampa-Guzmán, Andrea, Tavakkoli, Montreh, Oh, Timothy S., Reves, Heather, Jones, Daniel, Hanel, Walter, Christian, Beth, Ramakrishnan Geethakumari, Praveen, Karmali, Reem, Barta, Stefan K., Bartlett, Nancy L., Olszewski, Adam J., Epperla, Narendranath
Publicado 2023

Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy

por Yegya-Raman, Nikhil, Wright, Christopher M., LaRiviere, Michael J., Baron, Jonathan A., Lee, Daniel Y., Landsburg, Daniel J., Svoboda, Jakub, Nasta, Sunita D., Gerson, James N., Barta, Stefan K., Chong, Elise A., Schuster, Stephen J., Maity, Amit, Facciabene, Andrea, Paydar, Ima, Plastaras, John P.
Publicado 2023

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

por Epperla, Narendranath, Zhao, Qiuhong, Karmali, Reem, Torka, Pallawi, Shea, Lauren, Oh, Timothy S., Anampa-Guzmán, Andrea, Reves, Heather, Tavakkoli, Montreh, Greenwell, Irl Brian, Hansinger, Emily, Umyarova, Elvira, Annunzio, Kaitlin, Sawalha, Yazeed, Christian, Beth, Thomas, Colin, Barta, Stefan K., Geethakumari, Praveen Ramakrishnan, Bartlett, Nancy L., Grover, Natalie S., Olszewski, Adam J.
Publicado 2023

Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study

por Epperla, Narendranath, Welkie, Rina Li, Torka, Pallawi, Shouse, Geoffrey, Karmali, Reem, Shea, Lauren, Anampa-Guzmán, Andrea, Oh, Timothy S., Reaves, Heather, Tavakkoli, Montreh, Lindsey, Kathryn, Greenwell, Irl Brian, Hansinger, Emily, Thomas, Colin, Chowdhury, Sayan Mullick, Annunzio, Kaitlin, Christian, Beth, Barta, Stefan K., Geethakumari, Praveen Ramakrishnan, Bartlett, Nancy L., Herrera, Alex F., Grover, Natalie S., Olszewski, Adam J.
Publicado 2023

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy

por Choi, Yun, Caro, Jessica, Li, Xiaochun, Al-Obeidi, Arshed, Kurtz, Sharyn Lynn, Kim, Austin I., Chang, Julie E., Olszewski, Adam J., Zayac, Adam, Matthews, Andrew, Barta, Stefan K., Sundaram, Suchitra, Hernandez-Ilizaliturri, Francisco J., Leslie, Lori A., Caimi, Paolo, Carter, Jordan, David, Kevin A., Evens, Andrew M., Kim, Myung Sun, Nagle, Sarah J., Goldberg, Judith, Diefenbach, Catherine S.
Publicado 2021

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort

por Bowers, Jackson T., Anna, Jacob, Bair, Steven M., Annunzio, Kaitlin, Epperla, Narendranath, Pullukkara, Jerrin Joy, Gaballa, Sameh, Spinner, Michael A., Li, Shuning, Messmer, Marcus R., Nguyen, Joseph, Ayers, Emily C., Wagner, Charlotte B., Hu, Boyu, Di, Mengyang, Huntington, Scott F., Furqan, Fateeha, Shah, Nirav N., Chen, Christina, Ballard, Hatcher J., Hughes, Mitchell E., Chong, Elise A., Nasta, Sunita D., Barta, Stefan K., Landsburg, Daniel J., Svoboda, Jakub
Publicado 2023